Debra Hawes, MD

Title(s)Associate Professor of Clinical Pathology
AddressCHL 4650 Sunset Blvd
Off Campus
Los Angeles CA 90027
Phone+1 323 442 1156
vCardDownload vCard
    Other Positions
    Title(s)Director of Pathology Core Lab


    Collapse Overview 
    Collapse Overview
    Dr. Hawes began her education by pursuing a certificate in vocational nursing from Santa Ana College followed by a BA degree in French from Cal State Fullerton. She then attended medical school, and upon graduation she was first introduced to the Keck School of Medicine as a resident in the pathology department at LAC+USC Medical Center. While in medical school, Dr. Hawes demonstrated a profound aptitude for her studies when she was awarded to the Dean’s List of Outstanding Achievement in the Basic Sciences. Currently, Dr. Hawes is an assistant professor of clinical pathology and an instructor of the Pathology Multidisciplinary Laboratories at USC. She has reviewed manuscripts for the several medical journals, including the prestigious New England Journal of Medicine. In addition to her vast academic and clinical responsibilities, Dr. Hawes has a number of research interests, such as cancer prevention, new technology development and biologic markers of disease progression. Dr. Hawes has co-authored nearly 30 peer-reviewed journal articles and a number of book chapters and abstracts.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma. Acta Neuropathol Commun. 2021 06 23; 9(1):113. Alturkustani M, Cotter JA, Mahabir R, Hawes D, Koschmann C, Venneti S, Judkins AR, Szymanski LJ. PMID: 34162441.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab037. Ji J, Kaneva K, Hiemenz MC, Dhall G, Davidson TB, Erdreich-Epstein A, Hawes D, Hurth K, Margol AS, Mathew AJ, Robison NJ, Schmidt RJ, Tran HN, Judkins AR, Cotter JA, Biegel JA. PMID: 33948563.
      View in: PubMed   Mentions:
    3. Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project. Urol Oncol. 2021 05; 39(5):301.e17-301.e28. Wang G, Black PC, Goebell PJ, Ji L, Cordon-Cardo C, Schmitz-Dräger B, Hawes D, Czerniak B, Minner S, Sauter G, Waldman F, Groshen S, Cote RJ, Dinney CP. PMID: 33563539.
      View in: PubMed   Mentions:    Fields:    
    4. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Cancer Cell. 2020 09 14; 38(3):334-349.e9. Chung C, Sweha SR, Pratt D, Tamrazi B, Panwalkar P, Banda A, Bayliss J, Hawes D, Yang F, Lee HJ, Shan M, Cieslik M, Qin T, Werner CK, Wahl DR, Lyssiotis CA, Bian Z, Shotwell JB, Yadav VN, Koschmann C, Chinnaiyan AM, Blüml S, Judkins AR, Venneti S. PMID: 32795401.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    5. Corticospinal Wallerian Degeneration Before Myelination: A Case Report. Pediatr Dev Pathol. 2020 Sep-Oct; 23(5):399-403. Szymanski LJ, Hawes D, Gilles F. PMID: 32406814.
      View in: PubMed   Mentions:    Fields:    
    6. Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma. Acta Neuropathol Commun. 2020 03 20; 8(1):37. Pratt D, Quezado M, Abdullaev Z, Hawes D, Yang F, Garton HJL, Judkins AR, Mody R, Chinnaiyan A, Aldape K, Koschmann C, Venneti S. PMID: 32197665.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution. JCO Precis Oncol. 2019; 3. Kaneva K, Yeo KK, Hawes D, Ji J, Biegel JA, Nelson MD, Bluml S, Krieger MD, Erdreich-Epstein A. PMID: 31179415.
      View in: PubMed   Mentions:
    8. Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma. PLoS One. 2019; 14(1):e0206394. Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A. PMID: 30608927.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    9. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol. 2017 11; 134(5):705-714. Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper MJ, Chavez L, Margol A, Pekmezci M, Chung C, Banda A, Bayliss JM, Curry SJ, Santi M, Rodriguez FJ, Snuderl M, Karajannis MA, Saratsis AM, Horbinski CM, Carret AS, Wilson B, Johnston D, Lafay-Cousin L, Zelcer S, Eisenstat D, Silva M, Scheinemann K, Jabado N, McNeely PD, Kool M, Pfister SM, Taylor MD, Hawkins C, Korshunov A, Judkins AR, Venneti S. PMID: 28733933.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    10. Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor. J Neurosurg Pediatr. 2017 Jul; 20(1):51-55. Kiehna EN, Arnush MR, Tamrazi B, Cotter JA, Hawes D, Robison NJ, Fong CY, Estrine DB, Han JH, Biegel JA. PMID: 28387643.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Cancer Prev Res (Phila). 2015 Oct; 8(10):942-51. Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, Sheth P, Martin SE, Hawes D, Russell C, MacDonald H, Tripathy D, Su MY, Ursin G, Pike MC. PMID: 26276750.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    12. Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer. Clin Cancer Res. 2014 Dec 15; 20(24):6277-83. Liu SV, Tsao-Wei DD, Xiong S, Groshen S, Dorff TB, Quinn DI, Tai YC, Engel J, Hawes D, Schally AV, Pinski JK. PMID: 25278449.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    13. Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness. Cancer Res. 2014 May 15; 74(10):2857-68. Little GH, Baniwal SK, Adisetiyo H, Groshen S, Chimge NO, Kim SY, Khalid O, Hawes D, Jones JO, Pinski J, Schones DE, Frenkel B. PMID: 24648349.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    14. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Front Oncol. 2013; 3:298. Yu SS, Spicer DV, Hawes D, Tseng CC, Yang CS, Pike MC, Wu AH. PMID: 24380073.
      View in: PubMed   Mentions:
    15. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. Leuk Lymphoma. 2014 Mar; 55(3):551-7. Morton LM, Kim CJ, Weiss LM, Bhatia K, Cockburn M, Hawes D, Wang SS, Chang C, Altekruse SF, Engels EA, Cozen W. PMID: 23772639.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    16. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the Los Angeles Cancer Surveillance Program. Cancer. 2013 Feb 15; 119(4):756-65. Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. PMID: 23319010.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    17. Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial. Contraception. 2012 Sep; 86(3):238-43. Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, Pike MC, Pearce CL. PMID: 22325110.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat. 2012 Apr; 132(2):653-60. Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL. PMID: 22083231.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    19. Ethnic differences in neuroendocrine expression in prostate cancer tissue. Anticancer Res. 2011 Nov; 31(11):3897-901. Dorff TB, Liu SV, Xiong S, Cai J, Hawes D, Pinski J. PMID: 22110216.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    20. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol. 2011 Nov 10; 29(32):4313-9. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, Landreneau RJ, Patterson GA, Inculet RI, Jones DR, Malthaner RA, Cohen RG, Ballman K, Putnam JB, Cote RJ. PMID: 21990404.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    21. Effects of the change in cutoff values for human epidermal growth factor receptor 2 status by immunohistochemistry and fluorescence in situ hybridization: a study comparing conventional brightfield microscopy, image analysis-assisted microscopy, and interobserver variation. Arch Pathol Lab Med. 2011 Aug; 135(8):1010-6. Atkinson R, Mollerup J, Laenkholm AV, Verardo M, Hawes D, Commins D, Engvad B, Correa A, Ehlers CC, Nielsen KV. PMID: 21809992.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011 Jul 27; 306(4):385-93. Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote R. PMID: 21791687.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    23. Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer. Prostate. 2011 Jun 01; 71(8):892-8. Pinski J, Xiong S, Wang Q, Stanczyk F, Hawes D, Liu SV. PMID: 21456071.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    24. Expression of receptors for luteinizing hormone-releasing hormone (LH-RH) in prostate cancers following therapy with LH-RH agonists. Clin Cancer Res. 2010 Sep 15; 16(18):4675-80. Liu SV, Schally AV, Hawes D, Xiong S, Fazli L, Gleave M, Cai J, Groshen S, Brands F, Engel J, Pinski J. PMID: 20670943.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    25. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res. 2009 May 01; 69(9):3736-45. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. PMID: 19366806.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    26. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Res Treat. 2009 Nov; 118(1):161-8. Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D. PMID: 19205874.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    27. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer. Anticancer Res. 2008 Jan-Feb; 28(1B):425-30. Mori R, Wang Q, Quek ML, Tarabolous C, Cheung E, Ye W, Groshen S, Hawes D, Togo S, Shimada H, Danenberg KD, Danenberg PV, Pinski JK. PMID: 18383880.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 2007 Oct; 38(10):1547-52. Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, Lee AS, Pinski J. PMID: 17640713.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    29. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):5987-93. Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, Lee AS, Cote RJ. PMID: 17062670.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    30. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006 Oct 01; 12(19):5615-21. Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ. PMID: 17020963.
      View in: PubMed   Mentions: 248     Fields:    Translation:HumansCells
    31. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006 Jul; 169(1):279-93. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. PMID: 16816380.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimalsCells
    32. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol. 2006 Jun 20; 24(18):2735-42. Pagliarulo V, Hawes D, Brands FH, Groshen S, Cai J, Stein JP, Lieskovsky G, Skinner DG, Cote RJ. PMID: 16782914.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    33. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res. 2006; 8(2):R24. Hawes D, Downey S, Pearce CL, Bartow S, Wan P, Pike MC, Wu AH. PMID: 16646977.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    34. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol. 2006 Apr; 175(4):1245-52. Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. PMID: 16515971.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    35. Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis. 2003; 6(3):213-24. Golubkov V, Hawes D, Markland FS. PMID: 15041797.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    36. Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study. Gynecol Oncol. 2002 Oct; 87(1):17-23. Hawes D, Liu PY, Muggia FM, Wilczynski S, Cote R, Felix J, Terada K, Belt RJ, Alberts DS. PMID: 12468337.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    37. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. Urology. 2002 Jan; 59(1):97-102. Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ. PMID: 11796289.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Debra's Networks
    Concepts (250)
    Derived automatically from this person's publications.
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _